scholarly journals Identification of SH3 Domain Proteins Interacting with the Cytoplasmic Tail of the A Disintegrin and Metalloprotease 10 (ADAM10)

PLoS ONE ◽  
2014 ◽  
Vol 9 (7) ◽  
pp. e102899 ◽  
Author(s):  
Henriette Ebsen ◽  
Marcus Lettau ◽  
Dieter Kabelitz ◽  
Ottmar Janssen
Keyword(s):  
2013 ◽  
Vol 22 (10) ◽  
pp. 1358-1365 ◽  
Author(s):  
Priya Katyal ◽  
Robbins Puthenveetil ◽  
Olga Vinogradova

2000 ◽  
Vol 352 (3) ◽  
pp. 883-892 ◽  
Author(s):  
Qing KANG ◽  
Yi CAO ◽  
Anna ZOLKIEWSKA

ADAM 12, a member of the ADAM (protein containing a disintegrin and metalloprotease) family of metalloproteaseŐdisintegrins, has been implicated in the differentiation and fusion of skeletal myoblasts, and its expression is dramatically up-regulated in many cancer cells. While the extracellular portion of ADAM 12 contains an active metalloprotease and a cell-adhesion domain, the function of the cytoplasmic portion is much less clear. In this paper, we show that the cytoplasmic tail of ADAM 12 mediates interactions with the non-receptor protein tyrosine kinase Src. The interaction is direct, specific, and involves the N-terminal proline-rich region in the cytoplasmic tail of ADAM 12 and the Src homology 3 (SH3) domain of Src. ADAM 12 and Src co-immunoprecipitate from transfected C2C12 cells, suggesting that the two proteins form a complex in vivo. Co-expression of Src and ADAM 12, but not ADAM 9, in C2C12 cells results in activation of the recombinant Src. Moreover, endogenous ADAM 12 associates with and activates endogenous Src in differentiating C2C12 cells. These results indicate that ADAM 12 may mediate adhesion-induced signalling during myoblast differentiation.


Blood ◽  
2012 ◽  
Vol 120 (21) ◽  
pp. 383-383
Author(s):  
Patrik Nygren ◽  
Lisa M. Span ◽  
David T. Moore ◽  
Hong Cheng ◽  
Heinrich Roder ◽  
...  

Abstract Abstract 383 An essential component of αIIbβ3-mediated outside-in signaling is activation of the tyrosine kinase c-Src, some of which is constitutively bound via its SH3 domain to the C-terminal Arg759-Gly760-Thr761 (RGT) sequence of the β3 cytoplasmic tail. RGT is quite different from the canonical polyproline sequence recognized by SH3 domains in which a polyproline helix packs against a shallow groove composed of aromatic residues (Tyr93, Tyr95, Tyr139 in c-Src). A specificity pocket located at the end of the groove and composed of residues from the n-Src- and RT-loops affects substrate specificity. Because of the obvious difference between RGT and polyproline sequences, we asked how RGT binds to the c-Src SH3 domain and what implications this has for c-Src regulation by αIIbβ3. Initially, we employed CD spectroscopy and tryptophan (Trp) fluorescence because these techniques are sensitive to changes in the local environment surrounding aromatic residues. However, there were no differences in the CD spectrum of the SH3 domain in absence or presence of the β3 peptide NITYRGT, whereas there was a clear shift in the presence of the core polyproline peptide RPLPPLP. Polyproline binding to Trp in the SH3 specificity pocket also results in a blue shift in Trp fluorescence from 355 nm to 347 nm; however, the fluorescence spectrum was essentially unchanged in the presence of NITYRGT. These experiments suggest that either the interaction of NITYRGT with SH3 is extremely weak and not observed at the concentrations used or occurs outside of the aromatic groove and the specificity pocket. Accordingly, we turned to NMR, a method able to detect weak protein-protein interactions. Two dimensional 1H-15N HSQC spectra of the SH3 domain in the presence of NITYRGT exhibited a number of changes in chemical shift compared to the spectrum in the absence of ligand. Sixteen residues located in the n-Src and RT-loops, grouped around the specificity pocket, had chemical shift changes > 0.05 ppm. The largest changes occurred in residues in or adjacent to the RT-loop, especially residues Arg98, Glu100, and Asp102. Of the resides forming the aromatic groove, only Tyr95 which is adjacent to the specificity pocket was perturbed by NITYRGT. Plots of the chemical shift changes for NH groups in SH3 vs. NITYRGT concentration were linear, indicating that the majority of SH3 domain was unbound. Further, a Kd for NITYRGT binding to SH3, estimated from these experiments, was between 175–350 mM. Next, we obtained HSQC spectra for SH3 in the presence of either RPLPPLP or a negative control peptide NITYEGK. Major perturbations due to RPLPPLP occurred in three regions: residues 98–103 (RT-loop), 116–122 (n-Src loop and specificity pocket), and residues 134–138; residues in the aromatic cluster were unaffected by the ligand. By contrast, only a handful of residues showed small perturbations in the presence of NITYEGK and there was no overlap between the affected residues and those affected by RPLPPLP. In conclusion, our results indicate that compared to polyproline sequences, the C-terminus of the β3 cytoplasmic tail binds to the c-Src SH3 domain in the region of the SH3 specificity pocket. Because chemical shifts for acidic residues located in the RT-loop were particularly sensitive to the presence of NITYRGT, it is likely that Arg759 in β3 makes an important contribution to the interaction. Moreover, we found that the interaction between NITYRGT and the c-Src SH3 domain is substantially weaker than was previously reported for the interaction of β3 with c-Src. This suggest the possibility that a third component is required for this interaction to occur under biological conditions. Recently we found that the β3 cytoplasmic tail in solution has weak affinity for the talin-1 FERM domain, but appending the tail to acidic phospholipids increased its affinity by three orders of magnitude. Since the c-Src SH3 domain contains a conserved patch of basic residues that are necessary for binding to acidic phospholipids, it is possible that the interaction of c-Src with β3 is also a ternary interaction in which protein-lipid interactions play an important role. Disclosures: No relevant conflicts of interest to declare.


Blood ◽  
2008 ◽  
Vol 112 (11) ◽  
pp. 2856-2856
Author(s):  
Davi d T. Moore ◽  
Anjali Ganjiwale ◽  
Hong Cheng ◽  
Heinrich Roder ◽  
William F. DeGrado ◽  
...  

Abstract Integrins are ubiquitously expressed α/β heterodimers that mediate cell-cell and cellextracellular matrix interactions. Integrins reside on the plasma membrane in a highly regulated dynamic equilibrium between an inactive resting state and an active ligand binding conformation. An essential feature of this equilibrium is the association and dissociation of integrin transmembrane (TM) and cytoplasmic domains. Thus, when integrins are inactive, the TM and cytoplasmic domains of their α and β subunits are in proximity; the domains separate when integrins assume their active conformations. Subsequent to ligand binding, integrins cluster to generate “outside-in” signals, believed to be initiated by the activation of integrin-associated c-Src and related kinases. The prototypic example of regulated integrin activation and outside-in signaling is the major platelet integrin αIIbβ3. We have employed exogenous αIIb TM binding peptides to stabilize the separated conformation of αIIbβ3 and better understand the link between integrin conformation and downstream signal transduction. These peptides activate αIIbβ3 independent of “inside-out” signal transduction and induce αIIbβ3-mediated platelet aggregation despite the presence of the inhibitory prostaglandin PGE1 or the metabolic inhibitors 2-deoxyglucose and NaN3. When platelets are stimulated by natural agonists such as ADP or thrombin, fibrinogen binds to αIIbβ3 after which the c-Src associated with the β3 cytoplasmic tail is activated. This results in a characteristic phosphotyrosine signal that can be detected by immunoblotting platelet lysates using phosphotyrosine-specific antibodies and can be inhibited by the αIIbβ3 antagonists abciximab and RGDS that inhibit fibrinogen binding and clustering of αIIbβ3 in the membrane. By contrast, exogenous αIIb TM binding peptides activate phosphotyrosine signaling in platelets in the presence of abciximab and RGDS. This clustering-independent signal transduction is both integrin- and Src-dependent as it is absent in β3 knockout mice and can be blocked by the Src inhibitors PP2 and dasatinib. To better understand how β3-associated Src kinases are activated, we investigated the interaction of c-Src with αIIbβ3 by NMR spectroscopy. It has been reported that the SH3 domain of c-Src interacts with the C-terminal three amino acids of β3, Arg-Gly-Thr. We synthesized short fragments of the β3 cytoplasmic domain containing this sequence and observed perturbations in the 15N-1H HSQC NMR spectrum of the c-Src SH3 domain. There were significant shifts in the backbone amide spectra for residues Arg19, Asp23, Leu24, Glu21, Thr20, Tyr55, and Asn36, as well as shifts in the spectra for the side chains of Trp42, Trp43, Asn37, and Asn59. Titration experiments revealed a dissociation constant of approximately 4 mM for β3 peptide binding to the SH3 domain. It is noteworthy that the perturbed residues are localized to one region of the SH3 domain and are located outside of the canonical polyproline binding groove, implying a new mode of SH3 interaction. Moreover, the weak interaction of c-Src with the β3 cytoplasmic domain is consistent with the high local concentrations of β3 and Src kinases at the platelet membrane and the dynamic nature of integrin protein-protein interactions. These results suggest that the cytoplasmic domain separation that accompanies αIIbβ3 activation may be sufficient to activate the Src kinases weakly associated with β3 cytoplasmic domain. Subsequent αIIbβ3 clustering and/or c-Src dissociation may then amplify the tyrosine phosphorylation signal to complete outside-in signaling.


Sign in / Sign up

Export Citation Format

Share Document